bioRxiv Science⌕ Search

Biology subjects

Sugita, M.

Publications and source records attributed to Sugita, M..

2 recordsLinked to original sources

Protocol for Membrane Permeability Prediction of Cyclic Peptides using Descriptors Obtained from Extended Ensemble Molecular Dynamics Simulations and Chemical Structures

Improving membrane permeability is crucial in cyclic peptide drug discovery. Although the approach based on molecular dynamics (MD) simulation is widely used, it is computationally expensive. Alternatively, machine learning can predict membrane permeability at negligible cost, but it requires a larger dataset. There are only 7991 experimental values of membrane permeability available at the newly developed database. Another challenge in predicting membrane permeability using machine learning arises from the unique stable conformation of each cyclic peptide, which is strongly related to membrane permeability but difficult to predict from chemical structure. Therefore, we developed a machine learning protocol using 3D descriptors obtained from MD simulations in addition to 2D descriptors obtained from chemical structure of cyclic peptides, respectively, to generate a universal model with a realistic computational cost. We targeted 252 peptides across four datasets and, to calculate their 3D descriptors, predicted their conformation outside the membrane, at the water/membrane interface, and in the membrane by MD simulations based on the replica exchange with solute tempering/replica exchange umbrella sampling method using 16 replicas. For machine learning, six different algorithms were used, ranging from simple methods such as ridge regression to more sophisticated methods such as XGBoost. The best prediction performance was obtained using XGBoost, with a Pearsons correlation coefficient R = 0.77 and root mean square error (RMSE) = 0.62. The important descriptors included those that describe the hydrophilicity and hydrophobicity of the peptide, conformational differences between inside and outside the membrane, and the degree of freedom of the peptide. We confirm the models ability to predict the membrane permeability of peptides that differ in chemical structure from the training data by predicting the external data consisting of 24 peptides and obtained R = 0.76, RMSE = 1.14. Furthermore, we extracted one of the four datasets of the training data, re-trained the model, and performed the prediction of the permeability coefficients of the extracted dataset. The results showed the models generic nature with R = 0.61 and RMSE = 0.74, when using position-specific (PS) 3D, and 2D descriptors. In such situations descriptors based on conformations obtained from MD are essential for the prediction.

biophysics↗

Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphoma

CD19-targeting chimeric antigen receptor T cells (CART19) have demonstrated significant effectiveness in treating relapsed or refractory large B-cell lymphoma (LBCL). However, they often fail to sustain durable remissions in more than half of all treated patients. Therefore, there is an urgent need to identify approaches to enhance CART19 efficacy. Here, we studied the impact of low-dose radiation on CART19 activity in vitro and find that radiation enhances the cytotoxicity of CART19 against LBCL by upregulating death receptors. Disrupting the FAS receptor diminishes this benefit, indicating that this pathway plays an important role in enhancing the cytotoxic effects of CAR T cells. To further validate these findings, we conducted in vivo studies using a lymphoma syngeneic mouse model delivering total body irradiation (TBI). We observed that delivering TBI at a single dose of 1Gy prior to CAR T cell infusion significantly improved CART19-mediated tumor elimination and increased overall survival rates. Importantly, we characterized several important effects of TBI, including enhanced lymphodepletion, improved T cell expansion and persistence, better intra-tumoral migration, and a more favorable, anti-tumor phenotypic composition of the T cells. In summary, for the first time, we have demonstrated preclinically that administering TBI before CART19 infusion significantly accelerates tumor elimination and improves overall survival. This approach holds promise for translation into clinical practice and serves as a valuable foundation for further research to enhance outcomes for patients receiving CART19 treatment.

cancer biology↗